Zejula 300 MG Oral Tablet

RxCUI: 2640214
RxNorm name: Zejula 300 MG Oral Tablet
Display name: Zejula 300 MG Oral Tablet
Full name: Zejula 300 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ZEJULA	NIRAPARIB	GlaxoSmithKline LLC	b7f675e2-159c-490c-b6f4-3f16d9492b7d	2026-07-28	Warnings, Adverse reactions	Exact identifier rxcui: 2640214

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
b7f675e2-159c-490c-b6f4-3f16d9492b7d	Zejula 300 MG Oral Tablet [PSN] · niraparib 300 MG Oral Tablet [Zejula] [SBD] · Zejula 300 MG Oral Tablet [SY]	3	9	These highlights do not include all the information needed to use ZEJULA safely and effectively. See full prescribing information for ZEJULA. ZEJULA (niraparib) tablets, for oral use Initial U.S. Approval: 2017	20260327